USP15 Maintains TGF-β Pathway Activity by Deubiquitinating TBR1 in Wound Healing

Yi-Xuan Zhao,Zi Wang,Chia-Kang Ho,Guo-You Zhang,Qing-Feng Li
DOI: https://doi.org/10.2139/ssrn.3247869
2018-01-01
Abstract:Wound healing is a process of cutaneous barrier reconstruction after skin injury that involves diversified cytokines and cells. Ubiquitin-specific peptidase 15 (USP15), similar to several deubiquitinating enzymes (DUBs), can remove ubiquitin chains from specific proteins to rescue them from degradation. However, the regulatory role of USP15 in wound healing remains unclear. Here, our research aimed to investigate the dynamic function of USP15 in wound healing. First, in USP15 knockout mice, we observed a significant delay in wound closure. In addition, inhibition of cell proliferation and migration was observed in USP15-silenced human dermal fibroblasts (HDFs). Through RNA sequencing, we revealed that the transforming growth factor-β (TGF-β) pathway was suppressed after USP15 knockdown. Furthermore, coimmunoprecipitation (Co-IP) demonstrated that USP15 could interact with the TGF-β receptor I (TBR1) and promote its deubiquitination, thereby maintaining TGF-β signalling pathway activity by enhancing TBR1 stability. Conclusively, these observations shed light on the function and mechanisms of USP15 modulation of the TGF-β signalling pathway in wound healing, thus providing a novel potential target for the treatment of refractory wounds.
What problem does this paper attempt to address?